Niclosamide has demonstrated a robust inhibitory effect on the expression of STAT3 and mTOR, involved respectively in inflammatory and autophagic pathways, in the spinal cord of ALS mice. Here, STAT3 is linked to amyotrophic lateral sclerosis.